Efavirenz I type crystal preparation method

A technology of efavirenz and type I, which is applied in the field of preparing efavirenz type I crystals, and can solve problems such as being unsuitable for industrial production

Active Publication Date: 2014-01-15
SHANGHAI DESANO PHARMA INVESTMENT +1
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] But in the above method, WO9833782 has also reported that efavirenz crystallizes in the heptane-tetrahydrofuran solvent system, and easily obtains type II crystal, so this method is not suitable for industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Efavirenz I type crystal preparation method
  • Efavirenz I type crystal preparation method
  • Efavirenz I type crystal preparation method

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0041] Preparation method of efavirenz type I crystal

[0042] The present invention provides a kind of preparation method of efavirenz type I crystal, comprising steps:

[0043] (1) A solution containing efavirenz is provided, wherein the solvent of the solution is an organic solvent or a mixed solvent composed of an organic solvent and an antisolvent, and the antisolvent is water, C 5-8 Aliphatic or C 5-10 Aromatic hydrocarbons, or combinations thereof;

[0044] Preferably, efavirenz is dissolved in an organic solvent or a mixed solvent composed of an organic solvent and an antisolvent to form an efavirenz-containing solution.

[0045] Preferably, the anti-solvent is selected from the group consisting of water, n-hexane, cyclohexane, n-heptane, or combinations thereof.

[0046] The water used in the present invention is purified water or pure water, such as distilled water or deionized water; preferably water that has been distilled once or twice.

[0047] Preferably, th...

Embodiment 1

[0071] Add 250 g of the raw material efavirenz into a mixed solvent of 1.2 L of ethanol and 1 L of water, and heat to 50° C. to dissolve completely. After the solution was cleared, the temperature was lowered to 35° C., 2.5 g of type I seed crystals were added, and the crystallization was carried out by heat preservation. After the crystals were precipitated, 1.2 L of water was added dropwise. After the dropwise addition, the mixture was incubated for 1 hour. Then the temperature was lowered to about 5° C., and aging was continued for 1 hour. Filter, collect filter cake, get wet product. Polarizing microscope observation and XRPD analysis were carried out on the wet product, and it was identified as type I crystal. The wet product was dried under reduced pressure at 80°C to obtain 247 g of efavirenz type I crystals. After testing, the XRPD pattern is as follows figure 1 As shown, the DSC spectrum is as image 3 As shown, the IR spectrum is as Figure 5 As shown, the pol...

Embodiment 2

[0073] Add 25g of efavirenz raw material into a mixed solvent of 125mL of ethanol and 100mL of water, and heat to 50°C to dissolve completely. After dissolving, lower the temperature to 40°C, add 0.5 g of mixed seed crystals of type I and type V (molar ratio 1:1), and keep warm for crystallization. After the crystals were precipitated, 100 mL of water was added dropwise. After the dropwise addition, the temperature was lowered to about 5° C., and the mixture was kept for aging for 1 hour. Filter, collect filter cake, get wet product. Polarizing microscope observation and XRPD analysis were carried out on the wet product, and it was identified as type I crystal. The wet product was dried under reduced pressure at 80°C to obtain 24.5 g of efavirenz type I crystals. After testing, the XRPD spectrum, DSC spectrum, IR spectrum, and polarizing microscope photos are basically consistent with those of Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method for preparing Efavirenz crystal I. In particular, the method disclosed in the present invention comprises the steps of: dissolving Efavirenz into an organic solvent or a mixed solvent of an organic solvent and an anti-solvent, and then crystallizing by controlling the temperature of the solution obtained to an appropriate temperature, so as to obtain the Efavirenz crystals I. The method is easy to operate; the Efavirenz crystal I prepared is stable; and the purity of the crystal form can reach above 99%.

Description

technical field [0001] The invention belongs to the technical field of medicines, in particular to a method for preparing efavirenz type I crystals. Background technique [0002] Efavirenz is a non-nucleoside inhibitor of HIV-1 reverse transcriptase developed by Merck, Germany. It can be used in combination with other retroviral inhibitors for the treatment of HIV-1 infection in children and adults. Efavirenz is also the first anti-HIV drug approved in the United States for 1-a-day use in adults with HIV-1 infection, and has become the most prescribed drug in the initial treatment of HIV-infected patients. [0003] Efavirenz chemical name: (S)-6-chloro-4-(cyclopropylacetylene)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazine- 2-keto, trade name: STOCRIN or SUSTIVA. Its structural formula is shown below. [0004] [0005] WO9833782 discloses type I crystal, type II crystal and type III crystal of efavirenz, and WO9964405 discloses two other crystal forms: type IV crys...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D265/18
CPCC07D265/18
Inventor李金亮赵楠张良
OwnerSHANGHAI DESANO PHARMA INVESTMENT